✦ LIBER ✦

Interferon-alfacon-1 shows efficacy in patients with chronic hepatitis C who have not responded to, or relapsed after, prior therapy with IFN-α-2b plus ribavirin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retreatment with IFN alfa 2B + ribavirin

✍ A. Gallego; J. Garcia-Samaniego; M. Diago; M. Pérez-Olmeda; M.D. Valeros; J. Enr 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Interferon alpha-2b and ribavirin in com

✍ Giuseppe Barbaro; Gabriella Di Lorenzo; Giancarlo Belloni; Luisella Ferrari; Ald 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Ribavirin/interferon α-2b (IFN) therapy

✍ Pimstone, Neville R.; Canio, John B.; Chiang, Michelle H.; Kokosinski, Janet; Po 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Prospective, randomised, controlled stud

✍ Ricardo Moreno-Otero 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Pegylated interferon alfa-2b plus ribavi

✍ Jacobson, Ira M.; Ahmed, Furqaan; Russo, Mark W.; Brown, Robert S.; Lebovics, Ed 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Pegylated interferon alfa-2b plus ribavi

✍ Jacobson, Ira M.; Russo, Mark W.; Brown, Robert S.; Lebovics, Edward; Min, Alber 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 157 KB